Last update 23 Jan 2025

KRAS G12C x CD3ε

Basic Info

Related Targets
KRAS G12CCD3ε

Related

1
Drugs associated with KRAS G12C x CD3ε
R023
Target
CD3ε x KRAS G12C
Mechanism
CD3ε agonists [+1]
Active Org.
New York University School of MedicineNew York University School of Medicine
Originator Org.
New York University School of MedicineNew York University School of Medicine
Active Indication
Non-Small Cell Lung Cancer
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with KRAS G12C x CD3ε
Login to view more data
100 Translational Medicine associated with KRAS G12C x CD3ε
Login to view more data
0 Patents (Medical) associated with KRAS G12C x CD3ε
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free